Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06058650 · ClinicalTrials.gov registry record · NA
Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities
A NA study of Breast Neoplasm, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT06058650 is a NA study of Breast Neoplasm that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 70 participants, below the 160-participant average among 26 other Breast Neoplasm trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06058650, a NA study of Breast Neoplasm, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial tests how well molecular breast imaging (MBI) works to guide the collection of a breast biopsy in patients with a breast abnormality. Currently, a biopsy is often guided by either ultrasound or mammography in order to ensure that a sample of the correct part of the breast is taken. Sometimes a lesion or part of the lesion cannot be seen on ultrasound or mammography, and, therefore, a biopsy guided with ultrasound or mammography may not be always be accurate. Studies have shown that high resolution MBI may have potential to improve the detection of some breast tumors. This trial uses a new high-resolution MBI system that may help perform a biopsy using MBI.
Conditions Studied
Interventions
- OTHER Medical Device Usage and Evaluation
- PROCEDURE Biopsy of Breast
- RADIATION Scintimammography
- OTHER Technetium Tc-99m Sestamibi
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2021-08-26 |
| Est. Completion | 2026-08-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06058650
The ClinicalTrials.gov registry entry for NCT06058650 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 160-participant average among 26 other Breast Neoplasm trials with a reported enrollment target (56% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which Medical Device Usage and Evaluation is the first listed.
NCT06058650 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06058650 about?
NCT06058650 is a clinical study titled "Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities". This clinical trial tests how well molecular breast imaging (MBI) works to guide the collection of a breast biopsy in patients with a breast abnormality. Currently, a biopsy is often guided by either ultrasound or mammography in order to ensure that a sample of the correct part of the breast is take...
What is the current status of trial NCT06058650?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2021-08-26. Estimated completion is 2026-08-26.
What conditions does trial NCT06058650 study?
This clinical trial studies the following conditions: Breast Neoplasm.
What interventions are being tested in trial NCT06058650?
The interventions under investigation include: Medical Device Usage and Evaluation (OTHER), Biopsy of Breast (PROCEDURE), Scintimammography (RADIATION), Technetium Tc-99m Sestamibi (OTHER).
Who is sponsoring clinical trial NCT06058650?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06058650 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cryoablation vs Lumpectomy in T1 Breast Cancers
RECRUITING · NA
-
Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction
RECRUITING · NA
-
Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer
ACTIVE NOT RECRUITING · NA
-
Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting
COMPLETED · NA
-
Post-treatment Care of Breast Cancer Survivors
COMPLETED · NA
-
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.